Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Implants of Embryonic Tissue for Spinal Cord Injury

By HospiMedica staff writers
Posted on 19 Sep 2001
A small study has demonstrated that implanting human embryonic tissue in people with spinal cord injuries is both feasible and safe. More...
The study was conducted by researchers at the University of Florida (UF, Gainsville, FL, USA). Early findings were reported in two articles in the September 2001 issue of the Journal of Neurotrauma.

Nine surgeries were performed on eight patients at the UF medical center in July 1997 and February 2000. A neurosurgeon transplanted about a teaspoonful of tissue into the spinal cord of the patients, who needed an operation to drain and close fluid-filled cavities that had developed after their initial injuries. This condition, called syringomyelia, can cause unbearable pain and progressive loss of sensation and movement. An analysis of the initial two patients treated with the transplanted tissue showed that they had experienced no ill effects.

The researchers hoped that the transplanted tissue would grow enough to keep the cavities filled and prevent further deterioration. They have found some signs but no conclusive proof that the tissue did plug the cavities. The first patient experienced a decrease in the excessive firing of the nerve cells in his lower spinal cord, thought to be a source of spasticity in patients with spinal cord injuries. The patient also reported a sensation of increasing spasms in his leg, which the researchers thought might have been due to an overall increase in leg sensations.

"All we can tell for certain from magnetic resonance (MR) images is that the cysts were indeed collapsed where we placed the tissue,” said Dr. Edward D. Wirth, a UF professor of neuroscience and lead author of one article. "The MRI images do not enable us to distinguish between host tissue and transplant tissue, so we can't say for certain that the transplant survived.”




Related Links:
Univ. of Florida

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.